As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promis ...

Part 2: The cannabis health warning messages in this Part apply to edible cannabis products. Part 4: The cannabis health warning message in this Part applies to cannabis topical products. WARNING: Do ...

of the European Medicines Agency (EMA) has adopted a positive opinion recommending authorization of a label extension for IXCHIQ ®, Valneva’s single-dose vaccine for the prevention of disease ...

Egyptian Finance Minister Ahmed Kouchouk has announced that the Executive Board of the IMF has approved the fourth review of Egypt's financing program, amounting to $1.2 billion. According to ...

The Spanish bill, which needs to be approved by the lower house, classifies non-compliance with proper labelling of AI-generated content as a "serious offence" that can lead to fines of up to 35 ...

Exogenus Therapeutics and Lonza agreed to collaborate on the development of Exo-101, Exogenus’ exosome-based lead candidate. The company specializes in the development of therapeutics based on ...

Two new treatments have been approved for patients in the NHS (Dominic Lipinski/PA) Two new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish ...

The combination of Opdivo plus Yervoy was granted accelerated approval by the U.S. FDA in 2020 as a second-line treatment for patients with advanced HCC based on Phase 2 CheckMate -040 trial results.

Via early access, an individual healthcare system can support and fund treatment before European Medicines Agency (EMA) approval. As many as 18 European countries follow their own national procedures ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union ... for Medicinal Products for Human Use (CHMP) of the European Medicines ...

A durvalumab (Imfinzi)-based perioperative regimen has been recommended by the EMA Committee for the treatment of adults ... in combination with chemotherapy has been recommended for approval in the ...